#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal dystrophy Erythema multiforme Mantle cell lymphoma stage II Gaucher's disease type III Iron overload Atopic keratoconjunctivitis Thalassaemia beta Desmoid tumour Hypomagnesaemia Cutaneous T-cell lymphoma stage I Gestational trophoblastic tumour Mantle cell lymphoma stage III Hypocalcaemia Neuropathic arthropathy Allogenic stem cell transplantation More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis Mucopolysaccharidosis II – Basic Information Cystic fibrosis – Diagnostics Mucopolysaccharidosis – Life with Disease KBG syndrome – Treatment Ocular melanoma – Treatment Small intestine leiomyosarcoma – Basic Information Wiskott-Aldrich syndrome – Life with Disease Propionic acidaemia – Diagnostics Marfan’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefepime Hydrochloride R3R01 Salbutamol Stro-002 Esomeprazole Tiratricol Amikacin Sulfate IHMA-2121908-1 SODIUM SELENITE PENTAHYDRATE Absk021 Hydrochloride Hydrate Ly3541860 Cortisone Finerenone Teprotumumab Rineterkib Sodium Glycerophosphate Ag13909 VIPOGLANSTAT Degarelix Acetate Artemisia Vulgaris (312) More therapies…

    Learn about Your Condition

    Sickle cell disease Antisynthetase syndrome Medication overuse headache Metastases to meninges Abdominal wall pain Pyrexia Neonatal asphyxia Vascular malformation Ehlers-Danlos syndrome Adenocarcinoma pancreas Wheezing Undifferentiated sarcoma Uveal melanoma Systemic scleroderma Dry mouth More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Autologous Microfat and Platelet-Rich Plasma Injection Compared to Wrist Denervation in Patients with Radiocarpal Osteoarthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Autologous Microfat
    • Platelet Concentrate
    France

  • Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Oesophageal carcinoma
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Azd0901
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    Poland Spain

  • Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

    Recruiting

    3 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Givinostat
    Belgium France Germany Italy The Netherlands Spain

  • Study of Pembrolizumab and Lenvatinib for Patients with Resectable Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Austria

  • Study on the Effectiveness of Sphenopalatine Ganglion Block vs. Scalp Block in Patients Undergoing Craniotomy for Supratentorial Mass Using Levobupivacaine and Drug Combination

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cisatracurium Besilate
    • Etoricoxib
    • Levobupivacaine
    Belgium

  • Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zongertinib
    Belgium France Germany Italy The Netherlands Norway +1
Previous Page
1 … 360 361 362 363 364 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!